Clinical Trial Update: A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)

View source ↗

Summary

The ACCESS case-controlled etiologic study of sarcoidosis, sponsored by NHLBI, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Sarcoidosis | Status: COMPLETED